Dishman Carbogen Amcis Limited announced that the company's Bavla facility was successfully inspected by the US FDA in October 2018, which was intimated to the stock exchange on October 27, 2018. The company has received the Establishment Inspection Report (EIR) from the US FDA for this facility On January 28, 2019.